共 22 条
[1]
Rosuvastatin in older patientswith systolic heart failure. Kjekshus J,Apetrei E,Barrios V, et al. The New England Journal of Medicine . 2007
[2]
A prospective study of acute drug-induced liver injury in patients suffering from non-alcoholic fatty liver disease. TARANTINO G,CONCA P,BASILE V,et al. Hepatology Research . 2007
[3]
Heart disease and stroke statistics——2012 update:a report from the American Heart Association. ROGER V L,GO A S,LLOYD-JONES D M,et al. Circulation . 2012
[4]
Effect of n-3 polyunsaturated fatty acids in patients with chronic heart failure(the GISSI-HF trial):a randomised,double-blind,placebo-controlled trial. GISSI-HF Investigators. The Lancet . 2008
[5]
Randomized trial of an inhibitor of secretory phospholipase A2 on atherogenic lipoprotein subclasses in statin-treated patients with coronary heart disease. ROSENSON R S,ELLIOTT M,STASIV Y,et al. European Heart Journal . 2011
[6]
Effect of rosuvastatin in patients with chronic heart failure (the GISSI-HF trial):a randomised, double-blind, placebo-controlled trial. GISSI-HF investigators. The Lancet . 2008
[7]
Rosuvastatin to prevent vascular events inmen andwomenwith Elevated C-reactive protein. Ridker PM,Danielson E,Fonseca FAH,et al. The New England Journal of Medicine . 2008
[8]
Randomized clinical outcome trials of statins inheart failure. Fonarow GC. Heart Fail Clin . 2008
[9]
Coenzyme Q10:an independent predictor of mortality in chronic heart failure. Molyneux SL,Florkowski CM,George PM,et al. Journal of the American College of Cardiology . 2008
[10]
Biochemical functions of coenzyme Q10. Crane FL. Journal of the American College of Nutrition . 2001